Stay updated with breaking news from Nasdaq Amph. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Rating) issued its earnings results on Tuesday. The company reported $0.47 earnings per share for the quarter, topping analysts’ consensus estimates of $0.36 by $0.11, MarketWatch Earnings reports. Amphastar Pharmaceuticals had a return on equity of 17.35% and a net margin of 17.87%. During the same period last year, the […]
Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Rating) issued its earnings results on Tuesday. The company reported $0.47 EPS for the quarter, beating the consensus estimate of $0.36 by $0.11, MarketWatch Earnings reports. Amphastar Pharmaceuticals had a net margin of 17.87% and a return on equity of 17.35%. During the same period in the prior year, the […]
Wall Street brokerages expect that Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) will report $110.60 million in sales for the current fiscal quarter, according to Zacks Investment Research. Three analysts have provided estimates for Amphastar Pharmaceuticals’ earnings. The highest sales estimate is $118.20 million and the lowest is $106.50 million. Amphastar Pharmaceuticals posted sales of […]
Analysts expect Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) to report $0.33 earnings per share (EPS) for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for Amphastar Pharmaceuticals’ earnings, with estimates ranging from $0.29 to $0.37. Amphastar Pharmaceuticals posted earnings per share of $0.27 in the same quarter last year, which indicates […]
Zacks Investment Research upgraded shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Rating) from a hold rating to a strong-buy rating in a report published on Friday, Zacks.com reports. Zacks Investment Research currently has $39.00 price target on the stock. According to Zacks, “Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, […]